Insider sale
RETINALGENIX TECHNOLOGIES INC.
$729.3K
182.40K shares
What this filing means
BAYERN STEVEN plans to sell 182.40K shares of RETINALGENIX TECHNOLOGIES INC. valued at approximately $729.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2026ACC: 0001493152-26-028062
182.40K
Shares to sell
$729.3K
Approx. market value
4.21M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
EXERCISE WARRANT
CHECK
9/1/2018
4.21MTotal acquired4.21M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2018 | EXERCISE WARRANT CHECK | 4.21M | — |
| Total | 4.21M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
500.00
Market value
$1.7K
5/4/2026
Planned — Approximate Date
OTCQBPlanned
Units to sell
181.90K
Market value
$727.6K
6/11/2026
Total
Units
182.40K
Value
$729.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 500.00 | $1.7K | — | Completed |
| Planned — Approximate Date | ||||
6/11/2026 | 181.90K | $727.6K | OTCQB | Planned |
| Total | 182.40K | $729.3K | ||